Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine.

× No keyword cloud information.

5 in total

1. Estimating long-term cost savings from treatment of Alzheimer's disease. A modelling approach.

Authors: P Fenn; A Gray
Journal: Pharmacoeconomics Date: 1999-08 Impact factor: 4.981

Review 2. Recent developments in the drug treatment of Alzheimer's disease.

Authors: J J Sramek; N R Cutler
Journal: Drugs Aging Date: 1999-05 Impact factor: 3.923

Review 3. Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine.

Authors: A B Hauber; A Gnanasakthy; E H Snyder; M V Bala; A Richter; J A Mauskopf
Journal: Pharmacoeconomics Date: 2000-04 Impact factor: 4.981

4. The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model.

Authors: L Jönsson; P Lindgren; A Wimo; B Jönsson; B Winblad
Journal: Clin Ther Date: 1999-07 Impact factor: 3.393

5. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.

Authors: M Rösler; R Anand; A Cicin-Sain; S Gauthier; Y Agid; P Dal-Bianco; H B Stähelin; R Hartman; M Gharabawi
Journal: BMJ Date: 1999-03-06

5 in total

2 in total

Review 1. Amyloid beta: structure, biology and structure-based therapeutic development.

Authors: Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal: Acta Pharmacol Sin Date: 2017-07-17 Impact factor: 6.150

Review 2. Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: Current trends and future perspectives.

Authors: Livia La Barbera; Emanuele Mauri; Marcello D'Amelio; Manuele Gori
Journal: Front Neurosci Date: 2022-08-04 Impact factor: 5.152

2 in total